Literature DB >> 11520060

Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype.

H R Contreras1, M Fabre, F Granés, R Casaroli-Marano, N Rocamora, A G Herreros, M Reina, S Vilaró.   

Abstract

Members of the heparan sulfate proteoglycan family, the syndecans have emerged as integrators of extracellular signals, such as ECM components or growth factors, that activate cytoplasmic signaling cascades and regulate cytoskeletal functions. Specifically, syndecan-2 has been implicated in various cellular processes, from differentiation to migration, including its participation in cell-cell and cell-matrix adhesion. Here, we focused on the involvement of syndecan-2 in epithelial versus mesenchymal differentiation. Colorectal cancer-derived HT-29 M6 epithelial cells were stably transfected with full-length syndecan-2 cDNA, and the effect on cell morphology, adhesion, and mobility was evaluated. Characteristic features of migratory cells such as loss of intercellular contacts, flatter shape and multiple membrane projections were observed in syndecan-2 transfectants. Western blot analysis of the major component of epithelial adherens junctions, E-cadherin, revealed decreased expression levels. Furthermore, syndecan-2 induced stronger adhesion to collagen type I, specifically inhibited by heparin. This was correlated with an increased ability for migration, as demonstrated by wound healing experiments and transwell assays, without affecting their growth rate. These results indicate that syndecan-2 expression in mucus-secreting HT-29 M6 cells induces differentiation toward a migratory mesenchymal-like phenotype. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520060     DOI: 10.1006/bbrc.2001.5459

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Transcriptional gene expression profiles of HGF/SF-met signaling pathway in colorectal carcinoma.

Authors:  Xue-Nong Li; Yan-Qing Ding; Guo-Bing Liu
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

2.  Chemical Tumor Biology of Heparan Sulfate Proteoglycans.

Authors:  Karthik Raman; Balagurunathan Kuberan
Journal:  Curr Chem Biol       Date:  2010-01-01

3.  High expression of CASK correlates with progression and poor prognosis of colorectal cancer.

Authors:  Jin-Lai Wei; Zhong-Xue Fu; Min Fang; Qiu-Yuan Zhou; Qing-Ning Zhao; Jin-Bao Guo; Wei-Dong Lu; Hao Wang
Journal:  Tumour Biol       Date:  2014-06-14

4.  Altered expression patterns of syndecan-1 and -2 predict biochemical recurrence in prostate cancer.

Authors:  Rodrigo Ledezma; Federico Cifuentes; Iván Gallegos; Juan Fullá; Enrique Ossandon; Enrique A Castellon; Héctor R Contreras
Journal:  Asian J Androl       Date:  2011-02-14       Impact factor: 3.285

Review 5.  New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells.

Authors:  Innoc Han; Haein Park; Eok-Soo Oh
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

6.  Syndecan-2 regulates the migratory potential of melanoma cells.

Authors:  Jung-hyun Lee; Haein Park; Heesung Chung; Sojoong Choi; Younghwa Kim; Hyun Yoo; Tae-Yoon Kim; Hoo-Jae Hann; Ikjoo Seong; Jaesang Kim; Kathleen G Kang; Inn-Oc Han; Eok-Soo Oh
Journal:  J Biol Chem       Date:  2009-07-29       Impact factor: 5.157

Review 7.  Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.

Authors:  Renato V Iozzo; Ralph D Sanderson
Journal:  J Cell Mol Med       Date:  2011-05       Impact factor: 5.310

8.  Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148.

Authors:  James R Whiteford; Xiaojie Xian; Claire Chaussade; Bart Vanhaesebroeck; Sussan Nourshargh; John R Couchman
Journal:  Mol Biol Cell       Date:  2011-08-03       Impact factor: 4.138

Review 9.  Syndecans in tumor cell adhesion and signaling.

Authors:  DeannaLee M Beauvais; Alan C Rapraeger
Journal:  Reprod Biol Endocrinol       Date:  2004-01-07       Impact factor: 5.211

10.  Syndecan-2 is upregulated in colorectal cancer cells through interactions with extracellular matrix produced by stromal fibroblasts.

Authors:  Carolina Meloni Vicente; Ritchelli Ricci; Helena Bonciani Nader; Leny Toma
Journal:  BMC Cell Biol       Date:  2013-05-25       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.